Clinical trial
Quetiapine in Social Anxiety Disorder
NCT00215254 · Duke University, Other · Completed
Key facts
| NCT number | NCT00215254 |
|---|---|
| Title | Quetiapine in Social Anxiety Disorder |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Quetiapine in Social Anxiety Disorder |
| Lead sponsor | Duke University, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Social Anxiety Disorder |
| Intervention type | Drug |
| Interventions | quetiapine |
| Enrollment | 15 |
| Start date | Mar 1, 2004 |
| Completion | Feb 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 19, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: